Dara Khalatbari, MD
Ophthalmology · Monroe, NCNPI 1770612574
Payments from drug & device makers
Across 43 payments — averaging $508.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- LKC Technologies, Inc.$20K
- Alcon$2K
- Biotissue Holdings Inc.$183
- AbbVie$128
- Quidel Corporation$77
- Johnson & Johnson Surgical Vision, Inc.$41
- plus $181 from 7 others
What the payments were for
- Consulting fees$19,50089%
- Travel & lodging$8824%
- Food & beverage$1,4697%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| LKC Technologies, Inc. | 2 | $19,500 |
| Alcon | 26 | $1,742 |
| Biotissue Holdings Inc. | 1 | $183 |
| AbbVie | 2 | $128 |
| Quidel Corporation | 1 | $77 |
| Johnson & Johnson Surgical Vision, Inc. | 1 | $41 |
| NEW World Medical,inc. | 3 | $37 |
| Sight Sciences, Inc. | 2 | $36 |
| Glaukos Corporation | 1 | $26 |
| Rayner Intraocular Lenses Limited | 1 | $26 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 1 | $23 |
| Tearlab Corp | 1 | $20 |
| Amgen | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$21,851 in reported general payments places this provider in the 85th percentile of 588 ophthalmology providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 106 | $2,849 |
| Latanoprost | 144 | $1,347 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 62 | $615 |
| Ketorolac Tromethamine | 19 | $383 |
| Ofloxacin | 19 | $225 |
| ErythromycinErythromycin Base | 17 | $187 |
| Brimonidine Tartrate | 36 | $161 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 11 | $101 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Monroe
- Ivan MacMonroe$258K
- Glenn JaffeDurham$38.5M
- Lejla VajzovicDurham$7.5M
- Andrew AntoszykCharlotte$4M
- Majda HadziahmetovicDurham$2.4M
- Preeya GuptaRaleigh$2M
- Thomas WilliamsHickory$1.8M
- James HarrisHickory$1.4M
- Rajiv ShahWinston Salem$1.3M
- Patrick KeltyHickory$1.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.